Conceptual Evolution of Feasibility Studies in Pharmaceutical Development
The sole term ‘feasibility’ has multiple definitions in a clinical environment, leading to certain bias with all stakeholders involved, including pharma companies (sponsors) and all types of contract research organisations (CROs). The most common perception is related to a never-ending argument between pharma outsourcing 58 departments and CRO commercial groups, with sponsors expecting CROs to run a (non-defined) feasibility study prior to proposal submission and CROs undertaking a series of schematic actions to create an impression of fulfilled expectation. Anna Baran MD, Chief Medical Officer at KCR, shares her thoughts on feasibility..
https://international-pharma.com/wp-content/uploads/2017/01/KCR-Article-IPI-winter-16-Feasibility-.pdf
The sole term ‘feasibility’ has multiple definitions in a clinical environment, leading to certain bias with all stakeholders involved, including pharma companies (sponsors) and all types of contract research organisations (CROs). The most common perception is related to a never-ending argument between pharma outsourcing 58 departments and CRO commercial groups, with sponsors expecting CROs to run a (non-defined) feasibility study prior to proposal submission and CROs undertaking a series of schematic actions to create an impression of fulfilled expectation. Anna Baran MD, Chief Medical Officer at KCR, shares her thoughts on feasibility..
https://international-pharma.com/wp-content/uploads/2017/01/KCR-Article-IPI-winter-16-Feasibility-.pdf
